Annual EPS
-$2.03
+$1.49+42.33%
December 31, 2023
Summary
- As of February 7, 2025, ESPR annual earnings per share is -$2.03, with the most recent change of +$1.49 (+42.33%) on December 31, 2023.
- During the last 3 years, ESPR annual EPS has risen by +$3.20 (+61.19%).
- ESPR annual EPS is now at all-time high.
Performance
ESPR EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.15
+$0.18+54.55%
September 30, 2024
Summary
- As of February 7, 2025, ESPR quarterly earnings per share is -$0.15, with the most recent change of +$0.18 (+54.55%) on September 30, 2024.
- Over the past year, ESPR quarterly EPS has increased by +$0.18 (+54.55%).
- ESPR quarterly EPS is now -103.47% below its all-time high of $4.32, reached on June 30, 2020.
Performance
ESPR Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$0.64
+$0.22+25.58%
September 30, 2024
Summary
- As of February 7, 2025, ESPR TTM earnings per share is -$0.64, with the most recent change of +$0.22 (+25.58%) on September 30, 2024.
- Over the past year, ESPR TTM EPS has increased by +$0.22 (+25.58%).
- ESPR TTM EPS is now at all-time high.
Performance
ESPR TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
ESPR EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.3% | +54.5% | +25.6% |
| 3 y3 years | +61.2% | +54.5% | +25.6% |
| 5 y5 years | +73.1% | +94.0% | +82.8% |
ESPR EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.2% | -144.1% | +91.5% | at high | +93.3% |
| 5 y | 5-year | at high | +78.2% | -103.5% | +96.1% | at high | +94.7% |
| alltime | all time | at high | +88.1% | -103.5% | +96.8% | at high | +96.1% |
Esperion Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.15(-54.5%) | -$0.64(-25.6%) |
| Jun 2024 | - | -$0.33(-197.1%) | -$0.86(-13.1%) |
| Mar 2024 | - | $0.34(-168.0%) | -$0.99(-53.3%) |
| Dec 2023 | -$2.03(-42.3%) | -$0.50(+35.1%) | -$2.12(-10.9%) |
| Sep 2023 | - | -$0.37(-19.6%) | -$2.38(-15.6%) |
| Jun 2023 | - | -$0.46(-41.8%) | -$2.82(-17.3%) |
| Mar 2023 | - | -$0.79(+3.9%) | -$3.41(-3.9%) |
| Dec 2022 | -$3.52(-62.2%) | -$0.76(-6.2%) | -$3.55(-22.1%) |
| Sep 2022 | - | -$0.81(-22.9%) | -$4.56(-28.4%) |
| Jun 2022 | - | -$1.05(+12.9%) | -$6.37(-8.9%) |
| Mar 2022 | - | -$0.93(-47.5%) | -$6.99(-26.9%) |
| Dec 2021 | -$9.31(+78.0%) | -$1.77(-32.4%) | -$9.56(-18.2%) |
| Sep 2021 | - | -$2.62(+56.9%) | -$11.68(-3.7%) |
| Jun 2021 | - | -$1.67(-52.3%) | -$12.13(+97.6%) |
| Mar 2021 | - | -$3.50(-10.0%) | -$6.14(+12.0%) |
| Dec 2020 | -$5.23(+45.7%) | -$3.89(+26.7%) | -$5.48(+42.3%) |
| Sep 2020 | - | -$3.07(-171.1%) | -$3.85(+16.7%) |
| Jun 2020 | - | $4.32(-252.1%) | -$3.30(-65.7%) |
| Mar 2020 | - | -$2.84(+25.7%) | -$9.63(+158.9%) |
| Dec 2019 | -$3.59(-52.4%) | -$2.26(-10.3%) | -$3.72(+0.5%) |
| Sep 2019 | - | -$2.52(+25.4%) | -$3.70(+21.7%) |
| Jun 2019 | - | -$2.01(-165.5%) | -$3.04(+10.9%) |
| Mar 2019 | - | $3.07(-237.1%) | -$2.74(-63.7%) |
| Dec 2018 | -$7.54(+8.0%) | -$2.24(+20.4%) | -$7.54(+11.9%) |
| Sep 2018 | - | -$1.86(+8.8%) | -$6.74(0.0%) |
| Jun 2018 | - | -$1.71(-1.2%) | -$6.74(-3.0%) |
| Mar 2018 | - | -$1.73(+20.1%) | -$6.95(-1.0%) |
| Dec 2017 | -$6.98 | -$1.44(-22.6%) | -$7.02(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$1.86(-3.1%) | -$6.87(+18.9%) |
| Jun 2017 | - | -$1.92(+6.7%) | -$5.78(+29.0%) |
| Mar 2017 | - | -$1.80(+39.5%) | -$4.48(+34.5%) |
| Dec 2016 | -$3.33(+47.3%) | -$1.29(+67.5%) | -$3.33(+27.1%) |
| Sep 2016 | - | -$0.77(+24.2%) | -$2.62(+8.3%) |
| Jun 2016 | - | -$0.62(-4.6%) | -$2.42(+3.0%) |
| Mar 2016 | - | -$0.65(+12.1%) | -$2.35(+4.0%) |
| Dec 2015 | -$2.26(+1.8%) | -$0.58(+1.8%) | -$2.26(+4.1%) |
| Sep 2015 | - | -$0.57(+3.6%) | -$2.17(-3.1%) |
| Jun 2015 | - | -$0.55(-1.8%) | -$2.24(-2.2%) |
| Mar 2015 | - | -$0.56(+14.3%) | -$2.29(+2.2%) |
| Dec 2014 | -$2.22(-32.9%) | -$0.49(-23.4%) | -$2.24(-5.9%) |
| Sep 2014 | - | -$0.64(+6.7%) | -$2.38(+14.3%) |
| Jun 2014 | - | -$0.60(+17.6%) | -$2.08(+6.4%) |
| Mar 2014 | - | -$0.51(-19.3%) | -$1.96(+12.6%) |
| Dec 2013 | -$3.31(-79.6%) | -$0.63(+84.9%) | -$1.74(-64.9%) |
| Sep 2013 | - | -$0.34(-28.0%) | -$4.95(-46.5%) |
| Jun 2013 | - | -$0.47(+63.2%) | -$9.25(-29.7%) |
| Mar 2013 | - | -$0.29(-92.4%) | -$13.15(-19.1%) |
| Dec 2012 | -$16.25(+8.5%) | -$3.84(-17.2%) | -$16.25(+31.0%) |
| Sep 2012 | - | -$4.64(+5.8%) | -$12.41(+59.7%) |
| Jun 2012 | - | -$4.38(+29.3%) | -$7.77(+129.3%) |
| Mar 2012 | - | -$3.39 | -$3.39 |
| Dec 2011 | -$14.97(+118.7%) | - | - |
| Dec 2002 | -$6.85(+7.7%) | - | - |
| Dec 2001 | -$6.36(-62.9%) | - | - |
| Dec 2000 | -$17.12(+114.9%) | - | - |
| Dec 1999 | -$7.96 | - | - |
FAQ
- What is Esperion Therapeutics annual earnings per share?
- What is the all time high annual EPS for Esperion Therapeutics?
- What is Esperion Therapeutics annual EPS year-on-year change?
- What is Esperion Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly EPS year-on-year change?
- What is Esperion Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Esperion Therapeutics?
- What is Esperion Therapeutics TTM EPS year-on-year change?
What is Esperion Therapeutics annual earnings per share?
The current annual EPS of ESPR is -$2.03
What is the all time high annual EPS for Esperion Therapeutics?
Esperion Therapeutics all-time high annual earnings per share is -$2.03
What is Esperion Therapeutics annual EPS year-on-year change?
Over the past year, ESPR annual earnings per share has changed by +$1.49 (+42.33%)
What is Esperion Therapeutics quarterly earnings per share?
The current quarterly EPS of ESPR is -$0.15
What is the all time high quarterly EPS for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly earnings per share is $4.32
What is Esperion Therapeutics quarterly EPS year-on-year change?
Over the past year, ESPR quarterly earnings per share has changed by +$0.18 (+54.55%)
What is Esperion Therapeutics TTM earnings per share?
The current TTM EPS of ESPR is -$0.64
What is the all time high TTM EPS for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM earnings per share is -$0.64
What is Esperion Therapeutics TTM EPS year-on-year change?
Over the past year, ESPR TTM earnings per share has changed by +$0.22 (+25.58%)